Viamet Release: FDA Grants Fast Track Designation To VT-1598 For Treatment Of Valley Fever
Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of coccidioidomycosis, also known as Valley Fever. Valley Fever is an invasive fungal infection that is highly concentrated in the San Joachin Valley in California .
Start the conversation, or Read more at BioSpace.
Copyright © 2018 Topix LLC